Pegfilgrastim biosimilar (Sandoz)

培非格司亭生物类似药（山德士）

Report date: 2022/01/21 13:30:17

Base Information

Drug NamePegfilgrastim biosimilar (Sandoz)
Drug Alias Name培非司亭生物仿制药（山德士）PEGFILGRASTIM-BMEZ聚乙二醇非格司亭生物仿制药（山德士）Pegfilgrastimum (Sandoz)Pegfilgrastim (Sandoz) +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsFebrile NeutropeniaNeutropenia
Global Approved IndicationsFebrile NeutropeniaNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2018/11/22
Country/TerritoryUnited StatesUkraineRomania +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesClariant Produkte (Schweiz) Ag
China Registration ClassN/A

Develop Information

Active CompaniesClariant Produkte (Schweiz) AgSandoz IncSandoz Gmbh
Inactive CompaniesSandoz
Active IndicationsFebrile NeutropeniaNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA13
Related LinksN/A